It’s a DPP-4 inhibitor, a class with three other drugs in the U.S. The brand name in the U.S. is Nesina. It can be used with other drugs such as metformin and pioglitazone. The FDA’s press release of Jan. 25 has a little more info.
FDA Approves New T2 Diabetes Drug: Alogliptin
Comments Off on FDA Approves New T2 Diabetes Drug: Alogliptin
Filed under Uncategorized